Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

MAP2 Antikörper (pThr1613, pThr1619) (Cy5)

Der Kaninchen Polyklonal Anti-MAP2-Antikörper wurde für IF (cc) und IF (p) validiert. Er ist geeignet, MAP2 in Proben von Human, Maus und Ratte zu detektieren.
Produktnummer ABIN6984242

Kurzübersicht für MAP2 Antikörper (pThr1613, pThr1619) (Cy5) (ABIN6984242)

Target

Alle MAP2 Antikörper anzeigen
MAP2 (Microtubule-Associated Protein 2 (MAP2))

Reaktivität

  • 149
  • 96
  • 93
  • 28
  • 25
  • 5
  • 4
  • 4
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Human, Maus, Ratte

Wirt

  • 118
  • 53
  • 9
  • 2
Kaninchen

Klonalität

  • 129
  • 52
Polyklonal

Konjugat

  • 102
  • 15
  • 13
  • 5
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser MAP2 Antikörper ist konjugiert mit Cy5

Applikation

  • 137
  • 75
  • 43
  • 41
  • 38
  • 38
  • 32
  • 31
  • 31
  • 22
  • 21
  • 4
  • 4
  • 3
  • 2
  • 1
  • 1
Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Bindungsspezifität

    • 17
    • 16
    • 14
    • 14
    • 11
    • 8
    • 7
    • 7
    • 4
    • 4
    • 4
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    pThr1613, pThr1619

    Kreuzreaktivität

    Human, Maus, Ratte

    Homologie

    Dog,Cow,Pig,Horse,Chicken,Rabbit

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthesised phosphopeptide derived from human MAP2 around the phosphorylation site of Thr1613 and Thr1619

    Isotyp

    IgG
  • Applikationshinweise

    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    MAP2 (Microtubule-Associated Protein 2 (MAP2))

    Andere Bezeichnung

    MAP2

    Hintergrund

    Synonyms: MAP2(Phospho Thr1613/1619), MAP2 (phospho Thr1613/1619), p-MAP2 (phospho Thr1613/1619), MAP2(Phospho Thr1613/1619), MAP2(Phospho-Thr1613/1619), p-MAP2(Phospho-Thr1613/1619), DKFZp686I2148, Dendrite specific MAP, DKFZp686I2148, MAP 2, MAP-2, MAP2, MAP2_HUMAN, MAP2A, MAP2B, MAP2C, Microtubule associated protein 2, Microtubule-associated protein 2, Mtap 2.

    Background: MAP2 is the major microtubule associated protein of brain tissue. There are three forms of MAP2, two are similarily sized with apparent molecular weights of 280 kDa (MAP2a and MAP2b) and the third with a lower molecular weight of 70 kDa (MAP2c). In the newborn rat brain, MAP2b and MAP2c are present, while MAP2a is absent. Between postnatal days 10 and 20, MAP2a appears. At the same time, the level of MAP2c drops by 10-fold. This change happens during the period when dendrite growth is completed and when neurons have reached their mature morphology. MAP2 is degraded by a Cathepsin D-like protease in the brain of aged rats. There is some indication that MAP2 is expressed at higher levels in some types of neurons than in other types. MAP2 is known to promote microtubule assembly and to form side-arms on microtubules. It also interacts with neurofilaments, actin, and other elements of the cytoskeleton.

    Gen-ID

    4133

    UniProt

    P11137
Sie sind hier:
Chat with us!